• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性非卧床腹膜透析中腹膜转运的药理学调控

Pharmacological manipulation of peritoneal transport in CAPD.

作者信息

Steinhauer H B

机构信息

Department of Internal Medicine, University of Freiburg, FRG.

出版信息

Clin Nephrol. 1988;30 Suppl 1:S29-33.

PMID:3052958
Abstract

Various endogenous compounds and drugs influence different determinants of peritoneal transport. Catecholamines affect vascular diameter and mesenteric blood flow. Several gastrointestinal hormones were found to induce splanchnic vasodilation and to augment the effective vascular surface. Different prostanoids, histamine, and bradykinin influence peritoneal mass transfer by increasing vascular permeability. Vasodilative acting drugs, diuretics and surface active compounds were found to augment peritoneal solute clearances and water efflux by acting on peritoneal vessels or the serosal surface of the peritoneal membrane. Hyperosmolar dialysis solutions increase ultrafiltration and contribute to total peritoneal clearance by convective transport. The present paper aims to summarize the current knowledge on pharmacological and physiological manipulation of peritoneal transport function and to show some ways of its clinical use.

摘要

多种内源性化合物和药物会影响腹膜转运的不同决定因素。儿茶酚胺会影响血管直径和肠系膜血流量。已发现几种胃肠激素可诱导内脏血管舒张并增加有效血管表面积。不同的前列腺素、组胺和缓激肽通过增加血管通透性来影响腹膜物质转运。已发现具有血管舒张作用的药物、利尿剂和表面活性化合物可通过作用于腹膜血管或腹膜的浆膜表面来增加腹膜溶质清除率和水流出量。高渗透析液可增加超滤,并通过对流运输促进总的腹膜清除率。本文旨在总结目前关于腹膜转运功能的药理学和生理学调控的知识,并展示其临床应用的一些方式。

相似文献

1
Pharmacological manipulation of peritoneal transport in CAPD.持续性非卧床腹膜透析中腹膜转运的药理学调控
Clin Nephrol. 1988;30 Suppl 1:S29-33.
2
Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.持续性非卧床腹膜透析(CAPD)开始时糖尿病患者与非糖尿病患者之间液体和溶质转运的差异。
Adv Perit Dial. 1997;13:29-32.
3
[Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].[作为综合透析治疗重要组成部分的物质和水的腹膜转运动力学的扩展评估]
Pol Merkur Lekarski. 2004 Aug;17(98):110-3.
4
Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model.使用串联三孔膜/纤维基质模型对持续性非卧床腹膜透析中渗透超滤失败的模拟。
Am J Physiol Renal Physiol. 2007 Mar;292(3):F1035-43. doi: 10.1152/ajprenal.00251.2006. Epub 2006 Nov 7.
5
Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.伴有腹水的持续性非卧床腹膜透析(CAPD)患者溶质转运速率与引流液量之间的差异。
Adv Perit Dial. 1996;12:39-42.
6
[Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients].[硝普钠和振动对持续非卧床腹膜透析患者腹膜溶质转运的影响]
Hunan Yi Ke Da Xue Xue Bao. 2000 Aug 28;25(4):357-60.
7
Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.持续性非卧床腹膜透析患者的预后不能通过腹膜通透性特征来预测。
Adv Perit Dial. 2000;16:2-6.
8
Peritoneal kinetics of different drugs.不同药物的腹膜动力学
Clin Nephrol. 1988;30 Suppl 1:S24-8.
9
Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?氨基酸基透析液对稳定期持续性非卧床腹膜透析患者腹膜血流及通透性的影响:一氧化氮的潜在作用?
Clin Nephrol. 1996 May;45(5):295-302.
10
Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析期间腹膜结构和超微结构的变化及通透性改变
Proc Eur Dial Transplant Assoc. 1981;18:199-205.